Literature DB >> 3237145

Calculation of the dose delivered to organs outside the radiation beams.

P Francois1, C Beurtheret, A Dutreix.   

Abstract

An organ dose calculation based on measurements is described which models the total dose delivered outside a beam from 10 to 50 cm from the field edge. The dose distribution is parametrized for each beam energy as a function of depth, distance from the edge, and field size and shape. The algorithm also takes into account the organ location relative to the beam. Comparisons with measurements in an Alderson phantom using thermoluminescent dosimetry are given for various typical treatments.

Mesh:

Substances:

Year:  1988        PMID: 3237145     DOI: 10.1118/1.596170

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  11 in total

1.  A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy.

Authors:  Lydia J Jagetic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2015-06-04       Impact factor: 3.609

2.  Estimation of peripheral dose from Co60 beam in water phantom measured in Secondary Standard Dosimetry Laboratory, Pakistan.

Authors:  Muhammad Shahban; Babar Hussain; Khalid Mehmood; Shakeel Ur Rehman
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

3.  Peripheral dose measurement in high-energy photon radiotherapy with the implementation of MOSFET.

Authors:  Vassiliki Vlachopoulou; Georgia Malatara; Harry Delis; Kiki Theodorou; Dimitrios Kardamakis; George Panayiotakis
Journal:  World J Radiol       Date:  2010-11-28

Review 4.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

5.  Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy.

Authors:  Michael L Taylor; Tomas Kron
Journal:  J Med Phys       Date:  2011-04

6.  Epidemiological evidence for a common mechanism for neuroblastoma and differentiated thyroid tumour.

Authors:  F de Vathaire; P François; M Schlumberger; O Schweisguth; C Hardiman; E Grimaud; O Oberlin; C Hill; J Lemerle; R Flamant
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

7.  Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment.

Authors:  F de Vathaire; M Hawkins; S Campbell; O Oberlin; M A Raquin; J Y Schlienger; A Shamsaldin; I Diallo; J Bell; E Grimaud; C Hardiman; J L Lagrange; N Daly-Schveitzer; X Panis; J M Zucker; H Sancho-Garnier; F Eschwège; J Chavaudra; J Lemerle
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

8.  Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment.

Authors:  Boris Schwartz; Mohamed Amine Benadjaoud; Enora Cléro; Nadia Haddy; Chiraz El-Fayech; Catherine Guibout; Cécile Teinturier; Odile Oberlin; Cristina Veres; Hélène Pacquement; Martine Munzer; Tan Dat N'guyen; Pierre-Yves Bondiau; Delphine Berchery; Anne Laprie; Mike Hawkins; David Winter; Dimitri Lefkopoulos; Jean Chavaudra; Carole Rubino; Ibrahima Diallo; Jacques Bénichou; Florent de Vathaire
Journal:  Radiat Environ Biophys       Date:  2014-01-14       Impact factor: 1.925

9.  Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.

Authors:  Andrea Farioli; Marta Ottone; Alessio G Morganti; Gaetano Compagnone; Fabrizio Romani; Silvia Cammelli; Stefano Mattioli; Francesco S Violante
Journal:  Cancer Med       Date:  2016-02-10       Impact factor: 4.452

10.  Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.

Authors:  Andrea Farioli; Francesco Saverio Violante; Stefano Mattioli; Stefania Curti; David Kriebel
Journal:  Cancer Causes Control       Date:  2013-05-24       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.